Metabolic signature of 13 C-labeled wheat bran consumption related to gut fermentation in humans: a pilot study

EUROPEAN JOURNAL OF NUTRITION(2023)

引用 0|浏览24
暂无评分
摘要
Purpose The aim of this pilot study was to analyze concomitantly the kinetics of production of 13 C-labeled gut-derived metabolites from 13 C-labeled wheat bran in three biological matrices (breath, plasma, stools), in order to assess differential fermentation profiles among subjects. Methods Six healthy women consumed a controlled breakfast containing 13 C-labeled wheat bran biscuits. H 2 , CH 4 and 13 CO 2 , 13 CH 4 24 h-concentrations in breath were measured, respectively, by gas chromatography (GC) and GC-isotope ratio mass spectrometry (GC-IRMS). Plasma and fecal concentrations of 13 C-short-chain fatty acids (linear SCFAs: acetate, propionate, butyrate, valerate; branched SCFAs: isobutyrate, isovalerate) were quantified using GC-combustion-IRMS. Gut microbiota composition was assessed by16S rRNA gene sequencing analysis. Results H 2 and CH 4 24 h-kinetics distinguished two groups in terms of fermentation-related gas excretion: high-CH 4 producers vs low-CH 4 producers (fasting concentrations: 45.3 ± 13.6 ppm vs 6.5 ± 3.6 ppm). Expired 13 CH 4 was enhanced and prolonged in high-CH 4 producers compared to low-CH 4 producers. The proportion of plasma and stool 13 C-butyrate tended to be higher in low-CH 4 producers, and inversely for 13 C-acetate. Plasma branched SCFAs revealed different kinetics of apparition compared to linear SCFAs. Conclusion This pilot study allowed to consider novel procedures for the development of biomarkers revealing dietary fiber-gut microbiota interactions. The non-invasive assessment of exhaled gas following 13 C-labeled fibers ingestion enabled to decipher distinct fermentation profiles: high-CH 4 producers vs low-CH 4 producers. The isotope labeling permits a specific in vivo characterisation of the dietary fiber impact consumption on microbiota metabolite production. Clinical trial registration The study has been registered under the number NCT03717311 at ClinicalTrials.gov on October 24, 2018.
更多
查看译文
关键词
Short-chain fatty acids,Stable isotopes,Gut microbiota,13C-labeled dietary fiber,Methane,Branched short-chain fatty acids
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要